Compare STWD & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STWD | MIR |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Machinery/Components |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.2B |
| IPO Year | 2009 | N/A |
| Metric | STWD | MIR |
|---|---|---|
| Price | $18.06 | $22.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $20.13 | ★ $28.38 |
| AVG Volume (30 Days) | 3.2M | ★ 3.7M |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | ★ 10.67% | N/A |
| EPS Growth | ★ 4.55 | N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $1,844,289,000.00 | N/A |
| Revenue This Year | $282.53 | $23.84 |
| Revenue Next Year | $12.64 | $7.59 |
| P/E Ratio | ★ $15.66 | $195.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.59 | $12.00 |
| 52 Week High | $20.99 | $30.28 |
| Indicator | STWD | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 45.57 |
| Support Level | $17.73 | $19.53 |
| Resistance Level | $18.62 | $22.53 |
| Average True Range (ATR) | 0.32 | 1.07 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 69.64 | 46.85 |
Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment, and Investing & Servicing Segment. The company generates the majority of its revenue from the Commercial and Residential Lending Segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.